These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Possible systemic smooth muscle layer dysfunction due to a deficiency of dystrophin in Duchenne muscular dystrophy. Miyatake M; Miike T; Zhao J; Yoshioka K; Uchino M; Usuku G J Neurol Sci; 1989 Oct; 93(1):11-7. PubMed ID: 2681539 [TBL] [Abstract][Full Text] [Related]
46. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy. Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351 [TBL] [Abstract][Full Text] [Related]
47. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy. Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963 [TBL] [Abstract][Full Text] [Related]
49. Suppression of revertant fibers in mdx mice by expression of a functional dystrophin. Crawford GE; Lu QL; Partridge TA; Chamberlain JS Hum Mol Genet; 2001 Nov; 10(24):2745-50. PubMed ID: 11734539 [TBL] [Abstract][Full Text] [Related]
50. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Cui CH; Uyama T; Miyado K; Terai M; Kyo S; Kiyono T; Umezawa A Mol Biol Cell; 2007 May; 18(5):1586-94. PubMed ID: 17314403 [TBL] [Abstract][Full Text] [Related]
51. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model. Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121 [TBL] [Abstract][Full Text] [Related]
52. Integrative effects of dystrophin loss on metabolic function of the mdx mouse. Strakova J; Kamdar F; Kulhanek D; Razzoli M; Garry DJ; Ervasti JM; Bartolomucci A; Townsend D Sci Rep; 2018 Sep; 8(1):13624. PubMed ID: 30206270 [TBL] [Abstract][Full Text] [Related]
54. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice. Boer JM; de Meijer EJ; Mank EM; van Ommen GB; den Dunnen JT Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S118-24. PubMed ID: 12206806 [TBL] [Abstract][Full Text] [Related]
55. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy. Wasala NB; Bostick B; Yue Y; Duan D Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935 [TBL] [Abstract][Full Text] [Related]
56. Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. Law DJ; Allen DL; Tidball JG J Cell Sci; 1994 Jun; 107 ( Pt 6)():1477-83. PubMed ID: 7962191 [TBL] [Abstract][Full Text] [Related]
57. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice. Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141 [TBL] [Abstract][Full Text] [Related]
58. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Sacco A; Mourkioti F; Tran R; Choi J; Llewellyn M; Kraft P; Shkreli M; Delp S; Pomerantz JH; Artandi SE; Blau HM Cell; 2010 Dec; 143(7):1059-71. PubMed ID: 21145579 [TBL] [Abstract][Full Text] [Related]